- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02811029
Language and Motricity in Preterm School Age Children (LAMOPRESCO2)
A total of 40% of neurodevelopmental difficulties have been reported in very premature infants less than 32 weeks of age. The Epipage1 study reported a decreasing prevalence of cerebral palsy (9-6%) but a high prevalence of specific cognitive neurological difficulties and an increase in school failure.
Neurocognitive difficulties are numerous: visuospatial dyspraxia, language disorders, executive function disorders as well as attention and behaviour disorders. Developmental language disorders have been rarely reported in the literature. This originally prompted our request i.e. PHRC 2010 National Multicenter: LAMOPRESCO. For the past 3 years this protocol has studied the language development of children who were born very prematurely, aged 3 and a half years free of cerebral palsy, in particular the impact of a short rehabilitation period, precise, at an early stage, and protocolized on a fundamental sensorimotor language. The principal assessment criterion was the measurement of phonology, the cornerstone of oral and written language in humans. The aim of the present project is an analysis of the effect that this specific language stimulation has on the learning of written language. The hypothesis is that a specific work modifying various aspects of a child's language, during the age of 3 to 4, alters the development of phonological skills in a sustainable way. The acquisition of reading skills is basically dependent on the quality of its phonological components. The randomized study of children up to 8 years of age in a cohort of 150 children (LAMOPRESCO) will permit to confirm or refute this hypothesis. These increasing difficulties have been reported as regards the language understanding of 3 to 15 year old children. It is as if the initial difficulties and weaknesses, which moreover constituted oral language, prevented the use or development of neural networks, which became more complex and required both an oral and written language. Are these elements which constitute phonology, at an early stage, modifiable before the close of the clinically measurable developmental window?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aude CHAROLLAIS, MD
- Email: aude.charollais@chu-rouen.fr
Study Locations
-
-
-
Rouen, France
- Recruiting
- ROUEN university hospital
-
Contact:
- Aude CHAROLLAIS
- Email: aude.charollais@chu-rouen.fr
-
Sub-Investigator:
- Stéphane MARRET, Pr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Randomization in LAMOPRESCO-1 study
Exclusion Criteria:
- None as the same population as in the LAMOPRESCO study will be included
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: premature infants less than 32 weeks of age
measurement of phonology in premature infants less than 32 weeks of age who participated to LAMOPRESCO-1 study
|
measurement of phonology will be assess using BILO-3, EDA, VS and VL tests
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of reading speed
Time Frame: Day 1
|
Evaluation of reading speed will be assess using silent reading speed test.
Patient must read a list of words during 2 minutes.
The total number of read words will be analyse to calculate the reading speed.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of syntax level
Time Frame: Day 1
|
Patient must read a list of words during 2 minutes and select how much words are not correctly written.
|
Day 1
|
Evaluation of vocabulary level, syntax and understanding
Time Frame: Day 1
|
Patient must read a list of words during 2 minutes and select how much words are not correctly written.
|
Day 1
|
Evaluation of understanding level
Time Frame: Day 1
|
Patient must read a text and then answer oral questions about the history read.
|
Day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aude CHAROLLAIS, MD, ROUEN university hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2015/207/HP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Premature
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico
Clinical Trials on measurement of phonology
-
Samanth BurrUnknownSpeech Disorders in ChildrenUnited Kingdom
-
Austin Speech LabsUnknownAphasia | LanguageUnited States
-
University of Wisconsin, MadisonOffice of the Vice Chancellor for Research and Graduate Education; Wisconsin...Completed
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Helios Health Institute GmbHHeart Center Leipzig - University HospitalRecruitingCoronary Artery Disease | Coronary Artery StenosesGermany
-
GULIN FINDIKOGLUCompletedDiabetes Mellitus, Type 2 | Gait Disorder, SensorimotorTurkey
-
Hasselt UniversityTRACE labs Ziekenhuis Oost-Limburg (ZOL)Recruiting
-
Marmara UniversityCompletedVenous Insufficiency | Foot Drop (Acquired)Turkey
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Sotera Wireless, Inc.UnknownSleep Apnea, ObstructiveUnited States